pharma · Breast Neoplasms · Radiation Injuries
Sun Yat-sen Memorial
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-Sen Memorial is a pharma organization headquartered in CN. Primary therapeutic focus areas include Breast Neoplasms, Radiation Injuries, Breast Cancer, Platinum-resistant Recurrent Clear Cell Ovarian Cancer, Brea
Guangzhou, CN HQ
32 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Guangzhou, CN
- Employees
- 32
- Programs
- 7
- Drugs
- 16
- Patents
- 0
Carrellizumab + Capecitabine
Phase 3 · small molecule · Breast Neoplasms
Carrellizumab + Capecitabine for Breast Neoplasms is a Phase 3 program (small_molecule) at Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University with 1 ClinicalTrials.gov record(s).
Internal code SYSKY-2023-1282-02
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Breast Neoplasms
- Status
- active
- Trials
- 1